Doximity, Inc. Class A Common Stock (NY:DOCS)

29.92 UNCHANGED

Delayed Quote Updated: 7:00 PM EDT, Oct 14, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Doximity, Inc. Class A Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

31 32 Next >

1 Profitable Stock with Impressive Fundamentals and 2 We Brush Off

December 28, 2025

While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifies - as Jeff Bezos said, "Your margin is my...

Via StockStory

Doximity (NYSE:DOCS): A High-Growth Stock at a Key Technical Support Level ↗

December 27, 2025

Doximity (DOCS) exemplifies a growth stock with strong fundamentals and a promising technical setup, offering a potential entry point for investors.

Via Chartmill

The Great Rebalancing: How 'Magnificent Seven' Concentration Risk Sparked a Mid-Cap Renaissance in 2025

December 23, 2025

As the final trading days of 2025 wind down, the global financial landscape is witnessing a structural shift that many analysts are calling the "Great Rebalancing." For much of the last three years,...

Via MarketMinute

Earnings Scheduled For November 6, 2025 ↗

November 06, 2025

Via Benzinga

Doximity (DOCS) Stock Trades Up, Here Is Why

December 22, 2025

Shares of medical professional network Doximity (NYSE:DOCS) jumped 3.3% in the afternoon session after the stock's positive momentum continued as a Bank of America analyst reiterated a Buy rating and...

Via StockStory

Topics Artificial Intelligence Initial Public Offering

3 New Year’s Resolution Stocks That Could Turn Around in 2026 ↗

December 18, 2025

Via MarketBeat

3 Growth Stocks with Explosive Upside

December 17, 2025

Growth is oxygen. But when it evaporates, the consequences can be severe - ask anyone who bought Cisco in the Dot-Com Bubble or newer investors who lived through the 2020 to 2022 COVID cycle.

Via StockStory

1 Stock Under $50 for Long-Term Investors and 2 Facing Headwinds

December 16, 2025

The $10-50 price range often includes mid-sized businesses with proven track records and plenty of growth runway ahead. They also usually carry less risk than penny stocks, though they’re not immune to...

Via StockStory

Healthcare AI Exits Pilot Phase, Enters Production Deployment

December 12, 2025

Issued on behalf of VentriPoint Diagnostics Ltd.

From Equity Insider

Via GlobeNewswire

2 Small-Cap Stocks with Exciting Potential and 1 We Turn Down

December 10, 2025

Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings. However, these businesses (and their stock prices) often stay small...

Via StockStory

2 Software Stocks to Own for Decades and 1 We Brush Off

December 03, 2025

Software is eating the world, and virtually no business is left untouched by it. In the past, the undeniable tailwinds fueling SaaS companies led to lofty valuation multiples that made it easier to...

Via StockStory

Topics Artificial Intelligence Stocks

1 Oversold Stock Primed to Rebound and 2 That Underwhelm

December 01, 2025

Hitting a new 52-week low can be a pivotal moment for any stock. These floors often mark either the beginning of a turnaround story or confirmation that a company faces serious headwinds.

Via StockStory

Doximity (DOCS) Q2 2026 Earnings Call Transcript ↗

November 27, 2025

Doximity (DOCS) Q2 2026 Earnings Call Transcript

Via The Motley Fool

Topics Artificial Intelligence Earnings

Why Is Doximity (DOCS) Stock Soaring Today

November 21, 2025

Shares of medical professional network Doximity (NYSE:DOCS) jumped 9.9% in the afternoon session after Raymond James upgraded the stock's rating to Strong Buy, citing a compelling valuation.

Via StockStory

Topics Artificial Intelligence Earnings Stocks

Doximity, SentinelOne, Asure Software, Workday, and Bandwidth Shares Are Falling, What You Need To Know

November 20, 2025

A number of stocks fell in the afternoon session after markets faded the Nvidia rally in the morning session, as investors remained uncertain about future rate cuts.

Via StockStory

Topics Artificial Intelligence Earnings Stocks

1 Volatile Stock on Our Buy List and 2 We Ignore

November 18, 2025

A highly volatile stock can deliver big gains - or just as easily wipe out a portfolio if things go south. While some investors embrace risk, mistakes can be costly for those who aren’t prepared.

Via StockStory

Jim Cramer: Don't Buy This Health Care Stock Yet, It Is 'Still Too Expensive' ↗

November 13, 2025

On CNBC's "Mad Money Lightning Round," Jim Cramer recommended waiting and not buying Doximity, adding that it is "still too expensive."

Via Benzinga

5 Must-Read Analyst Questions From Doximity’s Q3 Earnings Call

November 13, 2025

Doximity’s third quarter results were marked by strong revenue and profit outperformance relative to Wall Street expectations, yet the market responded negatively. Management attributed the quarter’s...

Via StockStory

Topics Artificial Intelligence Earnings

This House of Representative Just Bought Up To $115K In Robinhood Markets Stock ↗

November 11, 2025

Via Benzinga

1 of Wall Street’s Favorite Stock to Target This Week and 2 We Brush Off

November 09, 2025

The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these forecasts with a grain of salt because...

Via StockStory

Topics Artificial Intelligence

DOCS Q3 Deep Dive: AI Integration and Upsell Timing Drive Revenue, Margin Pressures Emerge

November 07, 2025

Medical professional network Doximity (NYSE:DOCS) reported Q3 CY2025 results topping the market’s revenue expectations, with sales up 23.2% year on year to $168.5 million. The company expects next...

Via StockStory

Topics Artificial Intelligence

Doximity Inc (NYSE:DOCS) Tops Q2 FY2026 Estimates; Shares Fall on Guidance ↗

November 06, 2025

Doximity (DOCS) beat Q2 FY2026 earnings and revenue estimates, but shares fell on cautious future guidance. Revenue grew 23% YoY.

Via Chartmill

AI Stocks Extend Selloff, Nasdaq 100 Eyes Worst Week Since April: What's Moving Markets Friday? ↗

November 07, 2025

Risk-off sentiment dominated Wall Street on Friday, with selling pressure in AI-linked names intensifying and pushing technology stocks toward their worst week since April.

Via Benzinga

Topics Artificial Intelligence

Doximity’s (NYSE:DOCS) Q3: Beats On Revenue But Stock Drops

November 06, 2025

Medical professional network Doximity (NYSE:DOCS) announced better-than-expected revenue in Q3 CY2025, with sales up 23.2% year on year to $168.5 million. The company expects next quarter’s revenue to...

Via StockStory

Topics Artificial Intelligence

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

November 06, 2025

Via Benzinga

Doximity Announces Fiscal 2026 Second Quarter Financial Results

November 06, 2025

From Doximity

Via Business Wire

Doximity (DOCS) Reports Q3: Everything You Need To Know Ahead Of Earnings

November 04, 2025

Medical professional network Doximity (NYSE:DOCS) will be announcing earnings results this Thursday after market close. Here’s what you need to know.

Via StockStory

Topics Artificial Intelligence World Trade

3 Cash-Producing Stocks with Competitive Advantages

November 02, 2025

Businesses with strong free cash flow tend to be more adaptable and resilient. Some of these companies shine bright by using their cash wisely to strengthen their market positions.

Via StockStory

AI Stocks Slide Again, Bitcoin Dips Near $100,000: What's Moving Markets Thursday? ↗

November 06, 2025

After a brief and cautious rebound on Wednesday, risk-off sentiment returned sharply on Thursday, with AI-linked stocks leading a broad selloff across Wall Street and renewed pressure hitting crypto...

Via Benzinga

Topics Artificial Intelligence

Doximity (DOCS) Shares Skyrocket, What You Need To Know

October 27, 2025

Shares of medical professional network Doximity (NYSE:DOCS) jumped 5.2% in the afternoon session after Bank of America Securities upgraded its rating on the stock from 'Neutral' to 'Buy'.

Via StockStory

Topics Government Initial Public Offering

< Previous 1 2 3 4 5 6 7 8 9

...

31 32 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.